Albert DavidNSE:ALBERTDAVD -0.47%75 Interest Coverage is 0.08 as of Mar. 2026, which is 100% below its 10-year median of 51.55. GuruFocus rates NSE:ALBERTDAVD with a GF Score™ of 75/100 and a GF Value™ of ₹830.11 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 685 Drug Manufacturers companies, Albert David ranks worse than 145985.26% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Albert David's
Operating Income
for the
three
months ended in Mar. 2026 was ₹0 Mil. Albert David's Interest Expense for the
three
months ended in Mar. 2026 was ₹-4 Mil.
Albert David's interest coverage for the quarter that ended in Mar. 2026 was 0.08.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for Albert David's Interest Coverage or its related term are showing as below:
NSE:ALBERTDAVD's Interest Coverage is not ranked *
in the Drug Manufacturers industry.
Industry Median: 12.75 * Ranked among companies with meaningful Interest Coverage only.
Albert David (NSE:ALBERTDAVD) Interest Coverage Explanation
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Albert David Interest Coverage Related Terms
Albert David Interest Coverage Historical Data
* Premium members only.
The historical data trend for Albert David's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
NSE:ALBERTDAVD vs ZTS, UTHR: Interest Coverage Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Albert David's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Albert David Interest Coverage vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Albert David's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Albert David's Interest Coverage falls into.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Albert David (NSE:ALBERTDAVD) has a Interest Coverage of 0.08 as of Mar. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Albert David and its competitors. This is 100% below median its historical median of 51.55. According to the industry distribution chart, Albert David ranks #999999 out of 685 companies in the Drug Manufacturers industry.
Is Albert David's Interest Coverage too high?
Albert David's current Interest Coverage of 0.08 is 100% below median its 10-year median of 51.55. The Drug Manufacturers industry median Interest Coverage is 12.75. Albert David's value of 0.08 is 99.4% below this industry median. Based on the distribution chart, Albert David ranks #999999 out of 685 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Albert David has a GF Score™ of 75/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Albert David's Interest Coverage compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Albert David ranks #999999 out of 685 companies for Interest Coverage. This places Albert David in the lower half of its industry. The industry median Interest Coverage is 12.75. Albert David's value of 0.08 is 99.4% below this benchmark. While the company's 10-year median is 51.55 vs. the industry median of 12.75, Albert David has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Drug Manufacturers company?
The median Interest Coverage among Drug Manufacturers companies is 12.75, based on 685 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Albert David's current Interest Coverage of 0.08 is 99.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Albert David and its competitors. For the Drug Manufacturers industry, the median Interest Coverage is 12.75 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Albert David's current Interest Coverage is 0.08, which is 100% below median its own 10-year median of 51.55. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Albert David stock overvalued right now?
Based on GuruFocus' analysis, Albert David (NSE:ALBERTDAVD) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹830.11, compared to a current price of ₹705.05 — trading 15.1% below its estimated fair value. The current Interest Coverage is 0.08, which is 100% below median its 10-year median of 51.55 and 99.4% below the Drug Manufacturers industry median of 12.75. Albert David's overall GF Score™ is 75/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Albert David (NSE:ALBERTDAVD), the current Interest Coverage is 0.08 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Albert David (NSE:ALBERTDAVD) Overvalued in 2026?
Based on GuruFocus' analysis, Albert David stock appears to be undervalued.
The current stock price of ₹705.05 is trading 15.1% below its estimated GF Value™ of ₹830.11.
GuruFocus considers Albert David to be Modestly Undervalued.
Key valuation signals for NSE:ALBERTDAVD:
Interest Coverage: 0.08 (100% below median its 10-year median of 51.55)
GF Value™: ₹830.11 vs. price of ₹705.05 (15.1% below fair value)
Industry Position: 99.4% below the Drug Manufacturers median (#999999 of 685)
No single metric tells the full story. See the NSE:ALBERTDAVD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Albert David Ltd is engaged in the manufacturing and trading of pharmaceutical products. The company offers products such as pharmaceutical formulations, infusion solutions, herbal dosage forms, and bulk drugs. Its formulation product covers parenteral, oral, enteral, topical agents, and vision care solutions. The company exports its product to regions like Latin America, Southeast Asia, and a few African countries. The Company is only engaged in the manufacturing of pharmaceutical products, ipso facto, one reportable segment.
75GF Score
Get the complete analysis for NSE:ALBERTDAVD
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:ALBERTDAVD has been successfully added to your 
